Molybdenum

Molybdenum has been studied in 57 papers since 2017: 1 trial and 55 observational studies in people; 20 in the past year. It has not reached trials in people. The newest story, Nov 2, 2026: “Urinary cadmium linked to higher immune marker levels”.

ExposurePreclinical

57 papers study it17 findingsUpdated

MeSH

1 new paper in 30 daysSee all 56 papers on molybdenum

At a glance

Independent labs found the same change in people. 10 independent labs in 2 countries.

“molybdenum had a negative association with MS.”
Associations of urinary nicotine metabolites and essential metals with metabolic syndrome in older adults: The mediation effect of insulin resistanceJournal of hazardous materials2024doi:10.1016/j.jhazmat.2024.135969

1 of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 10 independent labs in 2 countries
  • 1 finding against
  • Funders: National Natural Science Foundation of China and others
  • Human trial1
  • Humans54
  • In silico1

What did studies of molybdenum find?

2

Studies of molybdenum measured 2 outcomes: alpha-Klotho and biological age.

Alpha-Klotho

upin humans1

1 study
  1. Molybdenum is linked with higher alpha-Klotho in humans after adjustment for potential confounders.

    Humansafter adjustment for potential confoundersn = 4,071

More on Alpha-Klotho

Biological age

upin humans1

1 study
  1. Molybdenum is linked with higher biological age in humans (β 1.50, 95% CI 0.15 to 2.85).

    Humansbloodn = 514

More on Biological age

What is molybdenum linked with?

10

Studies link molybdenum with 10 measures, most often metabolic syndrome (3 studies), dyslipidemia (2) and cognitive impairment (2).

Metabolic syndrome

downin humans3OR 0.852

3 studies
  1. Molybdenum is associated with metabolic syndrome in humans across plasma molybdenum quantiles (p-trend<0.05).

    Humansacross plasma molybdenum quantiles

  2. Molybdenum is linked with a lower risk of metabolic syndrome in humans after controlling for potential confounders (OR = 0.852, 95 % CI: 0.750-0.967).

    Humansafter controlling for potential confoundersurine

  3. Molybdenum is linked with a lower risk of metabolic syndrome in humans (Shenzhen, China).

    HumansShenzhen, Chinan = 4,564

More on Metabolic syndrome

Dyslipidemia

upin humans2OR 1.44–1.53

2 studies
  1. Molybdenum is associated with dyslipidemia in humans (OR 1.44 in the third quartile).

    Humansthird quartile

    Metal mixtures linked to abnormal blood fats in older adults

    Scientific reports
  2. Molybdenum is linked with a higher risk of dyslipidemia in humans (highest vs lowest quartile, multi-metal model) (OR 1.53, 95% CI 1.18-2.00).

    Humanshighest vs lowest quartile, multi-metal model

More on Dyslipidemia

Cognitive impairment

upin humans2

2 studies
  1. Molybdenum is linked with a higher risk of cognitive impairment in humans.

    Humansurinen = 1,230

  2. Molybdenum is linked with a higher risk of cognitive impairment in humans.

    Humansn = 441

More on Cognitive impairment

Hypertension

downin humans1upin humans1OR 1.08

2 studies
  1. Molybdenum is linked with a lower risk of hypertension in humans.

    Humansurine

  2. Molybdenum is linked with a higher risk of hypertension in humans (community-dwelling older adults) (OR: 1.08, 95% CI: 1.01-1.16).

    Humanscommunity-dwelling older adultsurinen = 3,733

More on Hypertension

Frailty

upin humans1

1 study
  1. Molybdenum is associated with frailty in humans.

    Humans

Triglyceride-glucose index

upin humans1

1 study
  1. Molybdenum is associated with triglyceride-glucose index in humans (Chinese elders).

    HumansChinese eldersn = 2,732

More on Triglyceride-glucose index

Amyloid-beta 42/40 ratio

upin humans1

1 study
  1. Molybdenum is associated with amyloid-beta 42/40 ratio in humans (+9.4% (95% CI: 0.8%, 18.6%)).

    Humansserumfemalesn = 194

More on Amyloid-beta 42/40 ratio

Poor sleep quality

downin humans1OR 0.927

1 study
  1. Molybdenum is linked with a lower risk of poor sleep quality in humans (OR = 0.927, 95%CI:0.867-0.990).

    Humansurinen = 3,957

High-density lipoprotein cholesterol

downin humans1

1 study
  1. Molybdenum is associated with high-density lipoprotein cholesterol in humans.

    Humans

More on High-density lipoprotein cholesterol

Population longevity indicators

upin humans1

1 study
  1. Molybdenum is associated with population longevity indicators in humans (county-level analysis in Guangdong Province, China).

    Humanscounty-level analysis in Guangdong Province, Chinaenvironmental background values

Latest

Dec 2025: 4Jan 2026: 2Feb 2026: 2Mar 2026: 0Apr 2026: 2May 2026: 2Jun 2026: 0Jul 2026: 1Aug 2026: 1Sep 2026: 1Oct 2026: 3Nov 2026: 119 papers in 12 months
Journal of the American Heart Association

Urinary cadmium linked to higher immune marker levels

An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.

Cohort · 5,148 peoplePopulations
Scientific Reports

Metal mixtures linked to abnormal blood fats in older adults

An observational study comparing 436 new cases with 872 controls during 2019–2023 linked urinary metal mixtures to dyslipidemia, or abnormal blood fat levels.An observational study comparing 436 new cases with 872 controls during 2019–2023 linked urinary metal mixtures to dyslipidemia, or abnormal blood fat levels.

Case-control studyPopulations

See all 56 papers on molybdenum